Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -58.74%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-45.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-35.83%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-35.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CytoMed Therapeutics Limited
Market Cap
$10.41M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-45.78%
3Y Avg
-35.83%
5Y Avg
-35.79%
Market Cap
$10.52M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-27.20%
3Y Avg
-100.49%
5Y Avg
-187.87%
Market Cap
$10.18M
Return on Invested Capital (ROIC)
-323.71%
TTM Avg
-133.57%
3Y Avg
-246.04%
5Y Avg
-170.10%
Market Cap
$10.65M
Return on Invested Capital (ROIC)
-95.42%
TTM Avg
-108.10%
3Y Avg
-72.41%
5Y Avg
-59.15%
Market Cap
$10.69M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-174.03%
3Y Avg
-198.05%
5Y Avg
-242.53%
Market Cap
$10.10M
Return on Invested Capital (ROIC)
-269.16%
TTM Avg
-387.93%
3Y Avg
-400.47%
5Y Avg
-400.47%
Market Cap
$9.98M
Return on Invested Capital (ROIC)
-55.13%
TTM Avg
-99.85%
3Y Avg
-167.97%
5Y Avg
-308.25%
Market Cap
$9.92M
Return on Invested Capital (ROIC)
-59.35%
TTM Avg
-68.11%
3Y Avg
-104.39%
5Y Avg
-133.77%
Market Cap
$10.94M
Return on Invested Capital (ROIC)
-216.67%
TTM Avg
-46.84%
3Y Avg
-98.66%
5Y Avg
-549.86%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $10.41M | N/A | -45.78% | -35.83% | -35.79% |
| Polyrizon Ltd. (PLRZ)vs › | $10.52M | N/A | -27.20% | -100.49% | -187.87% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | -323.71% | -133.57% | -246.04% | -170.10% |
| Lifeward Ltd. (LFWD)vs › | $10.65M | -95.42% | -108.10% | -72.41% | -59.15% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.69M | -240.64% | -174.03% | -198.05% | -242.53% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | -269.16% | -387.93% | -400.47% | -400.47% |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | -55.13% | -99.85% | -167.97% | -308.25% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.92M | -59.35% | -68.11% | -104.39% | -133.77% |
| BioVie Inc. (BIVI)vs › | $10.94M | -216.67% | -46.84% | -98.66% | -549.86% |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | -227.67% | -121.58% | -92.03% | -78.85% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -58.74% |
| 2025-09-30 | -48.30% |
| 2025-06-30 | -43.35% |
| 2025-03-31 | -43.73% |
| 2024-12-31 | -34.80% |
| 2024-09-30 | -20.27% |
| 2024-06-30 | -18.42% |
| 2024-03-31 | -28.11% |
| 2023-12-31 | -29.03% |
| 2023-09-30 | -38.23% |
| 2023-06-30 | -31.87% |
| 2023-03-31 | -22.30% |
| 2022-12-31 | -48.72% |
| 2022-09-30 | -45.38% |
| 2022-06-30 | -41.45% |
| 2022-03-31 | -50.91% |
| 2021-12-31 | -42.06% |
| 2021-09-30 | -30.26% |
| 2021-06-30 | -26.64% |
| 2021-03-31 | -17.63% |
| 2020-12-31 | -31.47% |
